Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
11/2005
11/02/2005EP1083905B1 Medical use of a selective estrogen receptor modulator in combination with a sex steroide precursor
11/02/2005EP1080095B1 Modulators of protein tyrosine phosphatases (ptpases)
11/02/2005EP1005493B1 Antiviral protease inhibitors
11/02/2005CN1225463C Arylated furane and thenoyl amine with potassium channel blocking effect
11/01/2005US6960693 Quaternary ammonium, phosphonium compound
11/01/2005US6960669 preparing benzo[b]thiophenecarbodithioic esters from the thioate with reduced equivalents of P2S5, alkali metal carbonate and catalyst in hot toluene; non-halogenated solvents; waste reduction;
11/01/2005US6960594 Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer
11/01/2005US6960588 Tryptase inhibitors
10/2005
10/27/2005WO2005100347A1 Methods for minimizing thioamide impurities
10/27/2005WO2005100345A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
10/27/2005WO2005100339A1 10-hydroxy-11-dihydroprostaglandin analogs as selective ep4 agonists
10/27/2005WO2005100338A1 5-morpholinylmethylthiophenyl pharmaceutial compounds as p38 map kinase modulators
10/27/2005WO2005100310A1 Thio-substituted arylmethanesulfinyl derivatives
10/27/2005WO2005100309A1 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
10/27/2005WO2005100308A1 Thio-substituted biaryl-methanesulfinyl derivatives
10/27/2005WO2005100305A1 Androgen modulators
10/27/2005WO2005100303A1 Indene derivatives and process for the preparation thereof
10/27/2005WO2005100301A1 2-aryloxyethyl glycine derivatives and their use as glycine transport inhibitors
10/27/2005WO2005100298A1 Cetp inhibitors
10/27/2005US20050240060 Low loss high refractive index vinyl sulfide compounds and method of making same
10/27/2005US20050240030 Process for producing n-monoalkyl-3-hydroxy-3-(2-thienyl)propanamine and intermediate
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050240017 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss
10/27/2005US20050239865 3-Cyano-2-amide-5,6-dihydrothieno[2,3-b]pyridine derivatives, e.g., tert-butyl 3-cyano-2-[(2-ethylbutanoyl)amino]-5,6-dihydrothieno[2,3-b]pyridine-7(4H) carboxylate; the compounds block the action of glucagon at its receptor and decrease the levels of plasma glucose to treat diabetes
10/27/2005US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
10/27/2005US20050239840 Benzothiophenes, formulations containing same, and methods
10/27/2005US20050239790 Substituted hydroxyethylamine aspartyl protease inhibitors
10/27/2005CA2563291A1 4-cyano-phenoxy-alkyl carboxyl derivatives as androgen modulators
10/27/2005CA2562554A1 Thio-substituted arylmethanesulfinyl derivatives
10/27/2005CA2562401A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
10/27/2005CA2562082A1 Cetp inhibitors for the treatment and prevention of atherosclerosis
10/27/2005CA2561554A1 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
10/26/2005EP1589019A1 Stereoselective process for the preparation of Clopidogrel
10/26/2005EP1589016A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
10/26/2005EP1589012A2 N-alkylheteroaryl secondary para-phenyldiamine, dyeing composition containing the same, process for making it and uses thereof
10/26/2005EP1589001A1 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
10/26/2005EP1589000A2 (R)-Chiral halogenated 1-substitutedamino-(N+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
10/26/2005EP1587802A1 3-methylamino-1-(2-thienyl)-1-propanone, production and use thereof
10/26/2005EP1587801A1 A process for preparing duloxetine and intermediates for use therein
10/26/2005EP1587798A2 Geminally di-substituted nsaid derivatives as abeta 42 lowering agents
10/26/2005EP1587782A1 3-aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake
10/26/2005EP1587781A1 3-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1289981A4 Novel electro-optic chromophore bridge compounds and donor-bridge compounds for polymeric thin film waveguides
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005EP1098870B1 Nitrate salt of Cetirizine
10/26/2005EP0835245B1 Substituted n-methylenethioureas as pesticides
10/26/2005CN1688588A Process and intermediates for the preparation of thienopyrrole derivatives
10/26/2005CN1688587A Process and intermediates for the preparation of the thienopyrrole derivatives
10/26/2005CN1688545A Phosphodiesterase 4 inhibitors, including n-substituted phenylamine and diphenylamine analogs
10/26/2005CN1688540A Novel vinyl carboxylic acid derivatives and their therapeutical use
10/26/2005CN1688527A Fused benzene derivative and use
10/26/2005CN1687057A Method for preparing duloxctine and important intermediate
10/26/2005CN1224622C Method for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene derivative
10/25/2005US6958352 Compounds for inhibiting insulin secretion and methods related thereto
10/25/2005US6958331 sulfonyl amine derivatives such as {2-(2,2-diphenyl-ethylamino)-5-[4-(4-isopropyl-piperazine-1-carbonyl)-piperidine-1-sulfonyl]-phenyl}-morpholin-4-yl-methanone; pain, inflammation, septic shock
10/25/2005US6958219 adding a labeled antibody, which binds to the autoinducer having a homoserine lactone ring with an N-acyl side chain, to a lysine-containing protein, and detection of immunospecific binding; N-(3-oxododecanoyl)-L-homoserine lactone
10/25/2005CA2331009C Compositions and methods of treatment for conditions responsive to testosterone elevation
10/25/2005CA2157191C Process for the hydrogenation of imines
10/20/2005WO2005097773A1 1,1’-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors
10/20/2005WO2005097100A2 Antibacterial agents
10/20/2005WO2005096734A2 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators
10/20/2005US20050234265 2-aminomethyl-5-tert-butyl-3-phenylphenol; antimalaria; used against protozoa of the genus Plasmodium, particularly emerging strains of drug-resistant Plasmodia
10/20/2005US20050234109 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050234081 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
10/20/2005US20050234058 Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
10/20/2005US20050234040 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
10/20/2005CA2561945A1 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators
10/20/2005CA2560648A1 1,1'-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors
10/20/2005CA2557010A1 Compounds and methods for treating dyslipidemia
10/19/2005EP1586570A1 Sulfonium salts, radiation-sensitive acid generators, and positive radiation-sensitive resin compositions
10/19/2005EP1586560A1 Thio-substituted arylmethanesulfinyl derivatives
10/19/2005EP1586559A1 Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
10/19/2005EP1586558A2 Bis-sulfonamide hydroxyethylamino retroviral protease inhinitors
10/19/2005EP1585745A1 Fc receptor modulating compounds and compositions
10/19/2005EP1585511A2 Asthma and allergic inflammation modulators
10/19/2005EP1383758A4 Novel process for preparing 5-aminomethyl-2-thiophenecarbonitrile. hcl by one-pot reaction
10/19/2005EP1144373B1 Serine protease inhibitors
10/19/2005CN1684958A Dihydro-dibenzo (A) anthracenes and relative compounds, composition and method
10/19/2005CN1684957A Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
10/19/2005CN1684944A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/19/2005CN1684939A Diastereoselective method of preparing olefins by means of the Horner-Wadsworth-Emmons reaction, comprising the addition of a tris-(polyoxaalkyl)-amine sequestering agent
10/19/2005CN1682702A Method for preparing medicine composition capable of inhibiting post infective virus proteinase
10/18/2005US6956054 Treatment of warm-blooded animals having a tumor or non-malignant hypervascularation, by administering a sufficient amount of a cytotoxic agent formulated into a phosphate prodrug form having substrate specificity for microvessel
10/18/2005US6956052 treatment of cancer and inflammation-associated disorders, such as arthritis; for example,1-[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide
10/13/2005WO2005095338A1 Alkoxyphenylpropanoic acid derivatives
10/13/2005WO2005095330A1 Novel dichloropropene derivatives
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005095326A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/13/2005WO2005095325A1 PROCESS FOR THE PREPARATION OF β-AMINOCARBOXYLIC ACIDS
10/13/2005WO2005094810A2 Novel pharmaceutical compositions
10/13/2005US20050228185 10-Hydroxy-11-dihydroprostaglandin analogs as selective EP4 agonists
10/13/2005US20050228179 Thionation of a carbonyl compound comprising a nitrile group, the presence of a decoy agent comprising a nitrile group
10/13/2005US20050228029 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis
10/13/2005US20050228017 Novel anticancer compounds
10/13/2005US20050228015 Substituted heteroaryl- and phenylsulfamoyl compounds
10/13/2005US20050227997 Selective inhibition of aggrecanase in osteoarthritis treatment
10/13/2005US20050227995 Phenyl sulfoxides and phenyl sulfones
10/13/2005US20050227994 Decomposition inhibitor for extracellular matrix of cartilage
1 ... 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 ... 329